Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Roche plans to invest over $700 million in setting up a new plant in North Carolina and up to $550 million in expanding its Indianapolis diagnostics hub.

Eli Lilly announced that its obesity therapy Zepbound delivered superior outcomes versus Novo Nordisk’s Wegovy across five ...

Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds over 72 weeks, ...

A 4.1 magnitude earthquake rattled eastern Tennessee and was felt all through the Southeastern states. 'The Big Weekend Show' ...

The 10th overall pick in the 2025 NFL Draft hadn't even been announced when the league dropped this year's schedule release date. Before NFL Commissioner Roger Goodell announced the Chicago Bears ...

Meteorologist Corey Simma has the latest forecast ...

The Yugo, the vehicle once dubbed as “the worst car in history” in the ’90s, is making a comeback after 17 years. A scale model of the new Yugo was unveiled in Germany and there are plans to start ...

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial. Lilly ...

Company to host conference call and webcast today at 8:00 a.m. ET--MIAMI, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Veru Inc.

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...